InsightfulValue
← Home

Amgen
Amgen

-8.01%

Healthcare & biotech / Biotechnology and Pharmaceuticals


πŸ”§ Tools

βœ… Due Diligence
Company at a Glance

More reviews (1)
Amgen

πŸ“Š Get full analytics about Amgen

Sign up for free or log in

πŸš€ Don’t miss "The Checklist Value Investor β€” A Smarter Way to Pick Stocks" β€” free!

Price
Live  
Overview
Amgen is a biotechnology company that specializes in developing innovative therapies for serious illnesses. The company was founded in 1980 in Thousand Oaks, California, and has since become one of the leading biotechnology companies in the world. Amgen's main focus areas include oncology, hematology, cardiovascular disease, inflammation, bone health, and neuroscience.
The company's products include biologic medicines used for the treatment of conditions such as cancer, kidney disease, bone disorders, and autoimmune diseases. One of Amgen's best-known products is Enbrel, a treatment for rheumatoid arthritis. The company also has a robust pipeline of potential new medications in various stages of development.
In addition to developing and manufacturing medicines, Amgen also conducts research and collaborates with other organizations in the biotechnology and healthcare industries. The company has a strong commitment to innovation and invests heavily in research and development to bring new and better treatments to patients.
Amgen is a global company with operations in more than 100 countries and a workforce of over 25,000 employees worldwide. The company has a strong track record of financial success and is consistently ranked as one of the top biotechnology companies in terms of revenue. Amgen has a strong corporate responsibility program and actively supports various philanthropic initiatives and community engagement efforts.
Overall, Amgen is a highly respected and successful biotechnology company that is dedicated to improving the lives of patients around the world through innovative medical treatments.
What is special about the company?
Amgen

πŸ“ˆ Want to read more about Amgen?

Sign up for free or log in

πŸš€ Don’t miss "The Checklist Value Investor β€” A Smarter Way to Pick Stocks" β€” free!

MS4gUGlvbm VlcmluZyBC aW90ZWNobm 9sb2d5IExl YWRlcjogQW 1nZW4gaXMg YSBsZWFkaW 5nIGJpb3Rl Y2hub2xvZ3 kgY29tcGFu eSB3aXRoIG EgZGVlcCBl eHBlcnRpc2 UgaW4gZGV2 ZWxvcGluZy BhbmQgbWFu dWZhY3R1cm luZyBpbm5v dmF0aXZlIH RoZXJhcGll cy4gSXQgaX Mgb25lIG9m IHRoZSBmaX JzdCBjb21w YW5pZXMgdG 8gaGFybmVz cyB0aGUgcG 90ZW50aWFs IG9mIGJpb3 RlY2hub2xv Z3kgdG8gcH JvZHVjZSBs aWZlLXNhdm luZyBtZWRp Y2luZXMsIG 1ha2luZyBp dCBhbiBpbm R1c3RyeSBw aW9uZWVyLj xicj4yLiBG b2N1cyBvbi BIdW1hbiBU aGVyYXBldX RpY3M6IEFt Z2VuIGZvY3 VzZXMgc29s ZWx5IG9uIG RldmVsb3Bp bmcgYW5kIG 1hbnVmYWN0 dXJpbmcgaH VtYW4gdGhl cmFwZXV0aW NzLCBtYWtp bmcgaXQgb2 5lIG9mIHRo ZSBmZXcgYm lvdGVjaCBj b21wYW5pZX MgdG8gZG8g c28uIFRoaX MgZm9jdXMg YWxsb3dzIH RoZSBjb21w YW55IHRvIG RlZGljYXRl IGFsbCBpdH MgcmVzb3Vy Y2VzIGFuZC BleHBlcnRp c2UgdG8gZG V2ZWxvcGlu ZyB0aGVyYX BpZXMgdGhh dCBjYW4gaW 1wcm92ZSB0 aGUgbGl2ZX Mgb2YgcGF0 aWVudHMuPG JyPjMuIERp dmVyc2UgUG 9ydGZvbGlv IG9mIFByb2 R1Y3RzOiBB bWdlbiBoYX MgYSBkaXZl cnNlIHBvcn Rmb2xpbyBv ZiBwcm9kdW N0cyB0aGF0 IGFkZHJlc3 MgYSB3aWRl IHJhbmdlIG 9mIHNlcmlv dXMgaWxsbm Vzc2VzLCBz dWNoIGFzIG NhbmNlciwg Y2FyZGlvdm FzY3VsYXIg ZGlzZWFzZS wgYW5kIGJv bmUgZGlzb3 JkZXJzLiBU aGlzIGRpdm Vyc2l0eSBh bGxvd3MgdG hlIGNvbXBh bnkgdG8gd2 VhdGhlciBj aGFuZ2VzIG luIG1hcmtl dCBkZW1hbm QgYW5kIGVu c3VyZXMgYS BzdGFibGUg cmV2ZW51ZS BzdHJlYW0u PGJyPjQuIF N0cm9uZyBS ZXNlYXJjaC BhbmQgRGV2 ZWxvcG1lbn QgUGlwZWxp bmU6IEFtZ2 VuIGludmVz dHMgaGVhdm lseSBpbiBy ZXNlYXJjaC BhbmQgZGV2 ZWxvcG1lbn QsIHdpdGgg YSBzdHJvbm cgZm9jdXMg b24gY3V0dG luZy1lZGdl IHNjaWVuY2 UgYW5kIGlu bm92YXRpdm UgdGVjaG5v bG9neS4gVG hlIGNvbXBh bnkgaGFzIG Egcm9idXN0 IHBpcGVsaW 5lIG9mIHBv dGVudGlhbC BuZXcgdGhl cmFwaWVzLC BkZW1vbnN0 cmF0aW5nIG l0cyBjb21t aXRtZW50IH RvIGJyaW5n aW5nIG5ldy B0cmVhdG1l bnRzIHRvIH BhdGllbnRz Ljxicj41Li BDb21taXRt ZW50IHRvIF BhdGllbnQg QWNjZXNzOi BBbWdlbiBp cyBjb21taX R0ZWQgdG8g ZW5zdXJpbm cgYWNjZXNz IHRvIGl0cy B0aGVyYXBp ZXMgZm9yIH BhdGllbnRz IGFyb3VuZC B0aGUgd29y bGQuIFRoZS Bjb21wYW55 IGFjdGl2ZW x5IHdvcmtz IHdpdGggZ2 92ZXJubWVu dHMsIHBheW VycywgYW5k IG90aGVyIH N0YWtlaG9s ZGVycyB0by BoZWxwIG1h a2UgaXRzIG 1lZGljaW5l cyBhZmZvcm RhYmxlIGFu ZCBhY2Nlc3 NpYmxlIHRv IHRob3NlIH dobyBuZWVk IHRoZW0uPG JyPjYuIEds b2JhbCBQcm VzZW5jZTog QW1nZW4gaG FzIGEgZ2xv YmFsIHByZX NlbmNlLCB3 aXRoIG9wZX JhdGlvbnMg aW4gbW9yZS B0aGFuIDEw MCBjb3VudH JpZXMsIG1h a2luZyBpdH MgbWVkaWNp bmVzIGFjY2 Vzc2libGUg dG8gcGF0aW VudHMgd29y bGR3aWRlLi BUaGUgY29t cGFueSBhbH NvIGhhcyBh IHN0cm9uZy BtYW51ZmFj dHVyaW5nIG NhcGFiaWxp dHksIGFsbG 93aW5nIGl0 IHRvIGVmZm ljaWVudGx5 IHByb2R1Y2 UgaXRzIHRo ZXJhcGllcy BhdCBhIGxh cmdlIHNjYW xlLjxicj43 LiBTdHJvbm cgQ29ycG9y YXRlIFNvY2 lhbCBSZXNw b25zaWJpbG l0eTogQW1n ZW4gaGFzIG Egc3Ryb25n IGNvbW1pdG 1lbnQgdG8g Y29ycG9yYX RlIHNvY2lh bCByZXNwb2 5zaWJpbGl0 eSwgd2l0aC BhIGZvY3Vz IG9uIGVudm lyb25tZW50 YWwgc3VzdG FpbmFiaWxp dHksIHByb2 1vdGluZyBz Y2llbmNlIG VkdWNhdGlv biwgYW5kIG ludmVzdGlu ZyBpbiB0aG UgY29tbXVu aXRpZXMgd2 hlcmUgaXQg b3BlcmF0ZX MuPGJyPjgu IFJlY29nbm l0aW9uIGFu ZCBBd2FyZH M6IEFtZ2Vu IGhhcyBiZW VuIGNvbnNp c3RlbnRseS ByZWNvZ25p emVkIGZvci BpdHMgY29u dHJpYnV0aW 9ucyB0byB0 aGUgYmlvdG VjaG5vbG9n eSBpbmR1c3 RyeSBhbmQg Y29tbWl0bW VudCB0byBw YXRpZW50IG NhcmUuIFRo ZSBjb21wYW 55IGhhcyBy ZWNlaXZlZC BudW1lcm91 cyBhd2FyZH MgYW5kIGFj Y29sYWRlcy Bmb3IgaXRz IHByb2R1Y3 RzLCBwaXBl bGluZSwgaW 5ub3ZhdGlv biwgYW5kIG NvcnBvcmF0 ZSBjaXRpem Vuc2hpcC48 YnI+OS4gU3 Ryb25nIEZp bmFuY2lhbC BQZXJmb3Jt YW5jZTogQW 1nZW4gaGFz IGEgdHJhY2 sgcmVjb3Jk IG9mIHN0cm 9uZyBmaW5h bmNpYWwgcG VyZm9ybWFu Y2UsIHdoaW NoIGhhcyBh bGxvd2VkIG l0IHRvIGlu dmVzdCBpbi ByZXNlYXJj aCBhbmQgZG V2ZWxvcG1l bnQsIGV4cG FuZCBpdHMg cG9ydGZvbG lvLCBhbmQg ZGVsaXZlci Bsb25nLXRl cm0gdmFsdW UgdG8gc2hh cmVob2xkZX JzLjxicj4x MC4gQ29sbG Fib3JhdGlv bnMgYW5kIF BhcnRuZXJz aGlwczogQW 1nZW4gaGFz IGEgaGlzdG 9yeSBvZiBz dWNjZXNzZn VsIGNvbGxh Ym9yYXRpb2 5zIGFuZCBw YXJ0bmVyc2 hpcHMgd2l0 aCBvdGhlci BiaW90ZWNo bm9sb2d5IG NvbXBhbmll cywgYWNhZG VtaWMgaW5z dGl0dXRpb2 5zLCBhbmQg cmVzZWFyY2 ggb3JnYW5p emF0aW9ucy 4gVGhlc2Ug Y29sbGFib3 JhdGlvbnMg aGVscCB0by BhZHZhbmNl IHNjaWVudG lmaWMga25v d2xlZGdlIG FuZCBicmlu ZyBuZXcgdG hlcmFwaWVz IHRvIG1hcm tldCBtb3Jl IHF1aWNrbH ku
What the company's business model?
Amgen

πŸ“ˆ Want to read more about Amgen?

Sign up for free or log in

✍️ Sign up to get "The Checklist Value Investor β€” A Smarter Way to Pick Stocks" for free

VGhlIEFtZ2 VuIGNvbXBh bnkncyBidX NpbmVzcyBt b2RlbCBpcy BiYXNlZCBv biB0aGUgZG V2ZWxvcG1l bnQsIHByb2 R1Y3Rpb24s IGFuZCBjb2 1tZXJjaWFs aXphdGlvbi BvZiBpbm5v dmF0aXZlIG Jpb3RlY2hu b2xvZ3kgbW VkaWNpbmVz LiBUaGlzIG luY2x1ZGVz IHJlc2Vhcm NoaW5nIGFu ZCBkaXNjb3 ZlcmluZyBu ZXcgdGhlcm FwZXV0aWMg c29sdXRpb2 5zIGZvciBk aXNlYXNlcy BhbmQgY29u ZGl0aW9ucy BzdWNoIGFz IGNhbmNlci wgY2FyZGlv dmFzY3VsYX IgZGlzZWFz ZXMsIGFuZC BpbmZsYW1t YXRvcnkgZG lzb3JkZXJz LiBBbWdlbi BhbHNvIGZv Y3VzZXMgb2 4gZ3Jvd2lu ZyBpdHMgcH JvZHVjdCBw b3J0Zm9saW 8gYW5kIGV4 cGFuZGluZy BpdHMgZ2xv YmFsIHJlYW NoIHRocm91 Z2ggY29sbG Fib3JhdGlv bnMgYW5kIH BhcnRuZXJz aGlwcy4gQW RkaXRpb25h bGx5LCBBbW dlbiBpbnZl c3RzIGluIG 5ldyB0ZWNo bm9sb2dpZX MgYW5kIGlu aXRpYXRpdm VzIHRvIGVu aGFuY2UgaX RzIHJlc2Vh cmNoIGFuZC BkZXZlbG9w bWVudCBjYX BhYmlsaXRp ZXMgYW5kIH N0cmVhbWxp bmUgaXRzIG 9wZXJhdGlv bnMuIFJldm VudWUgaXMg Z2VuZXJhdG VkIHRocm91 Z2ggdGhlIH NhbGUgb2Yg aXRzIHByb2 R1Y3RzIHRv IGhlYWx0aG NhcmUgcHJv dmlkZXJzLC BwYXRpZW50 cywgYW5kIH N0cmF0ZWdp YyBwYXJ0bm Vycy4=
Interesting facts about the company
Amgen

πŸ“ˆ Want to read more about Amgen?

Sign up for free or log in

πŸ™Œ Join now to get "The Checklist Value Investor β€” A Smarter Way to Pick Stocks" at no cost

CiAgICAgIC AgICAgIDxk aXYgc3R5bG U9J3dpZHRo OiAxMDAlOy BkaXNwbGF5 OiBmbGV4Oy BqdXN0aWZ5 LWNvbnRlbn Q6IGNlbnRl cjsnPgogIC AgICAgICAg ICAgICAgPG RpdiBzdHls ZT0nCiAgIC AgICAgICAg ICAgICAgIC AgZGlzcGxh eTogZmxleD sKICAgICAg ICAgICAgIC AgICAgICBh bGlnbi1pdG VtczogY2Vu dGVyOwogIC AgICAgICAg ICAgICAgIC AgIGJhY2tn cm91bmQtY2 9sb3I6ICNm MGY0Zjg7Ci AgICAgICAg ICAgICAgIC AgICAgYm9y ZGVyOiAxcH ggc29saWQg I2QxZTNmMD sKICAgICAg ICAgICAgIC AgICAgICBi b3JkZXItcm FkaXVzOiAx MHB4OwogIC AgICAgICAg ICAgICAgIC AgIHBhZGRp bmc6IDEwcH g7CiAgICAg ICAgICAgIC AgICAgICAg bWFyZ2luOi AyMHB4IDA7 CiAgICAgIC AgICAgICAg ICAgICAgZm 9udC1mYW1p bHk6ICJTZW dvZSBVSSIs IFJvYm90by wgc2Fucy1z ZXJpZjsKIC AgICAgICAg ICAgICAgIC AgICBib3gt c2hhZG93Oi AwIDJweCA2 cHggcmdiYS gwLCAwLCAw LCAwLjA1KT sKICAgICAg ICAgICAgIC AgICAgICBt YXgtd2lkdG g6IDkwMHB4 OwogICAgIC AgICAgICAg ICAgICAgIH dpZHRoOiAx MDAlOyc+Cg ogICAgICAg ICAgICAgIC AgICAgIDxp bWcgc3JjPS Jhc3NldHMv bG9nb3MvUG VTM1VEazVj VWl0S2RrR0 Mzd1Eud2Vi cCIgYWx0PS JBbWdlbiIg dGl0bGU9Ik FtZ2VuIiAg Y2xhc3M9Im ltZy1mbHVp ZCIgaGVpZ2 h0PTkwIHdp ZHRoPTkwIG xvYWRpbmc9 J2xhenknIH N0eWxlPSdi b3JkZXItcm FkaXVzOiA2 cHg7Jz4KCi AgICAgICAg ICAgICAgIC AgICAgPGRp diBzdHlsZT 0nZmxleDog MTsgdGV4dC 1hbGlnbjog Y2VudGVyOy BtYXJnaW4t bGVmdDogNX B4Oyc+CiAg ICAgICAgIC AgICAgICAg ICAgICAgID xwIHN0eWxl PSdmb250LX NpemU6IDI2 cHg7IGNvbG 9yOiAjMzMz OyBtYXJnaW 4tYm90dG9t OiAxNXB4Oy c+CiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC Dwn5OIIFdh bnQgdG8gcm VhZCBtb3Jl IGFib3V0IE FtZ2VuPwog ICAgICAgIC AgICAgICAg ICAgICAgIC A8L3A+Cgog ICAgICAgIC AgICAgICAg ICAgICAgIC A8YSBocmVm PSdpbmRleC 5waHA/cGFn ZT1zaWdudX AnIHN0eWxl PScKICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IGJhY2tncm 91bmQtY29s b3I6ICMwMD dCRkY7CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBjb2xv cjogI2ZmZj sKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIH BhZGRpbmc6 IDEwcHggMj BweDsKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIGJvcmRl ci1yYWRpdX M6IDVweDsK ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIHRl eHQtZGVjb3 JhdGlvbjog bm9uZTsKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIGZvbn Qtd2VpZ2h0 OiBib2xkOw ogICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgbW FyZ2luLXJp Z2h0OiAxMH B4OwogICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgdHJhbnNp dGlvbjogYm Fja2dyb3Vu ZC1jb2xvci AwLjNzIGVh c2U7JwogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgb25tb3 VzZW92ZXI9 J3RoaXMuc3 R5bGUuYmFj a2dyb3VuZE NvbG9yPSIj MDA1NmIzIi cKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIG 9ubW91c2Vv dXQ9J3RoaX Muc3R5bGUu YmFja2dyb3 VuZENvbG9y PSIjMDA3Qk ZGIic+CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBTaWdu IHVwIGZvci BmcmVlCiAg ICAgICAgIC AgICAgICAg ICAgICAgID wvYT4KCiAg ICAgICAgIC AgICAgICAg ICAgICAgID xzcGFuIHN0 eWxlPSdtYX JnaW46IDAg OHB4OyBjb2 xvcjogIzU1 NTsnPm9yPC 9zcGFuPgoK ICAgICAgIC AgICAgICAg ICAgICAgIC AgPGEgaHJl Zj0naW5kZX gucGhwP3Bh Z2U9bG9naW 4nIHN0eWxl PScKICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IGNvbG9yOi AjMDA3QkZG OwogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg dGV4dC1kZW NvcmF0aW9u OiB1bmRlcm xpbmU7CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBmb250 LXdlaWdodD ogNTAwOyc+ CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBs b2cgaW4KIC AgICAgICAg ICAgICAgIC AgICAgICAg PC9hPgoKCi AgICAgICAg ICAgICAgIC AgICAgICAg IDxwIHN0eW xlPSdtYXJn aW4tdG9wOi AxNXB4OyBm b250LXNpem U6IDEzcHg7 IGZvbnQtd2 VpZ2h0OiBi b2xkOyBjb2 xvcjogI2Qz MmYyZjsnPg ogICAgICAg ICAgICAgIC AgICAgICAg ICAgICAg8J +TpSBHZXQg b3VyIGZyZW UgZUJvb2sg bm93OiA8aT 4iVGhlIENo ZWNrbGlzdC BWYWx1ZSBJ bnZlc3Rvci DigJQgQSBT bWFydGVyIF dheSB0byBQ aWNrIFN0b2 NrcyI8L2k+ CiAgICAgIC AgICAgICAg ICAgICAgIC AgIDwvcD4K CiAgICAgIC AgICAgICAg ICAgICAgIC AgIDwhLS0K ICAgICAgIC AgICAgICAg ICAgICAgIC AgPGRpdiBz dHlsZT0nbW FyZ2luLXRv cDogMTJweD sgZm9udC1z aXplOiAxM3 B4OyBjb2xv cjogIzQ0ND snPgogICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgU2lnbiB1 cCBub3cgYW 5kIGdldCBv dXIgZnJlZS BlQm9vayAK ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIDxi PlRoZSBDaG Vja2xpc3Qg VmFsdWUgSW 52ZXN0b3Ig 4oCUIEEgU2 1hcnRlciBX YXkgdG8gUG ljayBTdG9j a3M8L2I+Ci AgICAgICAg ICAgICAgIC AgICAgICAg IDwvZGl2Pg ogICAgICAg ICAgICAgIC AgICAgICAg ICAtLT4KIC AgICAgICAg ICAgICAgIC AgICAgICAg PCEtLQogIC AgICAgICAg ICAgICAgIC AgICAgICA8 ZGl2IHN0eW xlPSdtYXJn aW4tdG9wOi AxNnB4OyBm b250LXNpem U6IDE0cHg7 IGNvbG9yOi AjNDQ0OyBm b250LWZhbW lseTogLWFw cGxlLXN5c3 RlbSwgQmxp bmtNYWNTeX N0ZW1Gb250 LCBTZWdvZS BVSSwgUm9i b3RvLCBIZW x2ZXRpY2Eg TmV1ZSwgc2 Fucy1zZXJp ZjsgbGluZS 1oZWlnaHQ6 IDEuNjsnPg ogICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgSG F2ZSB5b3Ug aGVhcmQgYW JvdXQgb3Vy IHNob3J0ID xzdHJvbmcg c3R5bGU9J2 ZvbnQtd2Vp Z2h0OiA2MD A7Jz5EYWls eSBWaWRlby BOZXdzbGV0 dGVyPC9zdH Jvbmc+Pwog ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgPGEg aHJlZj0naH R0cHM6Ly93 d3cuaW5zaW dodGZ1bHZh bHVlLmNvbS 9uZXdzbGV0 dGVyLnBocC cgdGFyZ2V0 PSdfYmxhbm snIHN0eWxl PSdjb2xvcj ogIzAwN0JG RjsgdGV4dC 1kZWNvcmF0 aW9uOiBub2 5lOyBmb250 LXdlaWdodD ogNTAwOyBt YXJnaW4tbG VmdDogNnB4 Oyc+CiAgIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgRm luZCBvdXQg bW9yZQogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgPC9hPg ogICAgICAg ICAgICAgIC AgICAgICAg ICA8L2Rpdj 4KICAgICAg ICAgICAgIC AgICAgICAg ICAgLS0+Ci AgICAgICAg ICAgICAgIC AgICAgPC9k aXY+CiAgIC AgICAgICAg ICAgICA8L2 Rpdj4KICAg ICAgICAgIC AgPC9kaXY+ CiAgICAgIC AgICAgIAog ICAgICAgIA ogICAgICAg IDxzcGFuIG NsYXNzPSdi bHVycmVkLX RleHQnPgog ICAgICAgIC AgICBNUzRn UVcxblpXID RnYzNSaGJt UnogSUdadm NpQkJjSCBC c2FXVmtJRT F2IGJHVmpk V3hoY2kgQk haVzVsZEds aiBjeXdnWV c1a0lIIGRo Y3lCdmNtbG 4gYVc1aGJH eDVJRyBadm RXNWtaV1Fn IGFXNGdNVG s0TUMgQmll U0IwYUhKbC BaU0J6WTJs bGJuIFJwYz NSeklIZHYg Y210cGJtY2 dZWCBRZ2RH aGxJRlZ1IG FYWmxjbk5w ZEgga2diMl lnUTJGcyBh V1p2Y201cF lTIHdnVEc5 eklFRnUgWj JWc1pYTXVQ RyBKeVBqSX VJRlJvIFpT QmpiMjF3WV cgNTU0b0Na Y3lCbSBhWE p6ZENCd2Nt IDlrZFdOME lIZGggY3lC MGFHVWdZVy A1MGFTMWhi bVZ0IGFXRW daSEoxWnkg QkZjbmwwYU hKdiBjRzlw WlhScGJpIH dnZDJocFky Z2cgZDJGek lHRndjSCBK dmRtVmtJR0 o1IElIUm9a U0JHUkUgRW dhVzRnTVRr NCBPU0JoYm 1RZ2NtIFYy YjJ4MWRHbH YgYm1sNlpX UWdkRyBobE lIUnlaV0Yw IGJXVnVkQ0 J2WmkgQmhi bVZ0YVdFZy BhVzRnYTJs a2JtIFY1SU dScGMyVmgg YzJVZ2NHRj BhVyBWdWRI TXVQR0p5IF BqTXVJRUZ0 WjIgVnVJR2 x6SUhSbyBa U0JzWVhKbl pYIE4wSUdK cGIzUmwgWT JodWIyeHZa MyBrZ1kyOX RjR0Z1IGVT QnBiaUIwYU cgVWdkMjl5 YkdRcyBJSG RwZEdnZ1lT IEJ0WVhKcl pYUWcgZG1G c2RXVWdiMi BZZ2IzWmxj aUFrIE1UUX dJR0pwYkcg eHBiMjRnWV hNZyBiMlln TWpBeU1TID Q4WW5JK05D NGcgU1c0Z1 lXUmthWCBS cGIyNGdkRz hnIFJYSjVk R2h5YjMgQn ZhV1YwYVc0 cyBJRUZ0Wj JWdUlHIGho Y3lCa1pYWm wgYkc5d1pX UWdZUyBCM2 FXUmxJSEpo IGJtZGxJRz ltSUcgbHVi bTkyWVhScC BkbVVnYldW a2FXIE5wYm 1WeklHWnYg Y2lCelpYSn BiMyBWeklH UnBjMlZoIG MyVnpJSE4x WTIgZ2dZWE 1nWTJGdSBZ MlZ5TENCdm MzIFJsYjNC dmNtOXogYV hNc0lHRnVa QyBCdGFXZH lZV2x1IFpT NDhZbkkrTl MgNGdRVzFu Wlc0ZyBhR0 Z6SUdFZ2Mz IFJ5YjI1bk lHTnYgYlcx cGRHMWxibi BRZ2RHOGdj bVZ6IFpXRn lZMmdnWVcg NWtJR1JsZG 1WcyBiM0J0 Wlc1MExDIE JwYm5abGMz UnAgYm1jZ2 IzWmxjaSBB a05DQmlhV3 hzIGFXOXVJ R0Z1Ym4gVm hiR3g1SUds dSBJSFJvWl NCa2FYIE5q YjNabGNua2 cgWVc1a0lH UmxkbSBWc2 IzQnRaVzUw IElHOW1JRz VsZHkgQjBj bVZoZEcxbC BiblJ6TGp4 aWNqIDQyTG lCVWFHVWcg WTI5dGNHRn VlUyBCb1lY TWdZU0J3IG NtVnpaVzVq WlMgQnBiaU J2ZG1WeSBJ REV3TUNCam IzIFZ1ZEhK cFpYTWcgWV c1a0lHVnRj RyB4dmVYTW diM1psIGNp QXlNeXd3TU QgQWdjR1Z2 Y0d4bCBJSG R2Y214a2Qy IGxrWlM0OF luSSsgTnk0 Z1FXMW5aVy A0Z2FHRnpJ R0VnIGJHOX VaeUJvYVgg TjBiM0o1SU c5bSBJR052 Ykd4aFltID l5WVhScGIy NXogSUdGdV pDQndZWCBK MGJtVnljMm hwIGNITWdk MmwwYUMgQn ZkR2hsY2lC aiBiMjF3WV c1cFpYIE1n WVc1a0lHRm ogWVdSbGJX bGpJRyBsdW MzUnBkSFYw IGFXOXVjeX dnWVcgeHNi M2RwYm1jZy BabTl5SUhS b1pTIEJsZU dOb1lXNW4g WlNCdlppQn BaRyBWaGN5 QmhibVFnIF lXTmpaWE56 SUggUnZJR0 4xZEhScCBi bWN0WldSbl pTIEIwWldO b2JtOXMgYj JkNUxqeGlj aiA0NExpQk VaWE53IGFY UmxJR2wwY3 kgQnphWHBs SUdGdSBaQ0 J6ZFdOalpY IE56TENCQm JXZGwgYmlC b1lYTWdabS BGalpXUWdZ MmhoIGJHeG xibWRsY3kg QnBiaUJ5Wl dObCBiblFn ZVdWaGNuIE 1zSUdsdVky eDEgWkdsdV p5QndZWCBS bGJuUWdaWG h3IGFYSmhk R2x2Ym4gTW dZVzVrSUds dSBZM0psWV hObFpDIEJq YjIxd1pYUn AgZEdsdmJp QnBiaSBCMG FHVWdZbWx2 IGNHaGhjbT FoWTIgVjFk R2xqWVd3Zy BhVzVrZFhO MGNuIGt1UE dKeVBqa3Ug SUZSb1pTQm piMiAxd1lX NTVJR2x6IE lHdHViM2R1 SUcgWnZjaU JwZEhNZyBj M1J5YjI1bk lHIE52Y25C dmNtRjAgWl NCemIyTnBZ VyB3Z2NtVn pjRzl1IGMy bGlhV3hwZE gga2dhVzVw ZEdsaCBkR2 wyWlhNc0lH IGx1WTJ4MV pHbHUgWnlC d2FHbHNZVy A1MGFISnZj R2xqIElHVm 1abTl5ZEgg TWdkRzhnYV c1aiBjbVZo YzJVZ1lXIE 5qWlhOeklI UnYgSUdobF lXeDBhRyBO aGNtVWdZVz VrIElITjFj SEJ2Y24gUW dabTl5SUhO aiBhV1Z1WT JVZ1pXIFIx WTJGMGFXOX UgTGp4aWNq NHhNQyA0Z1 FXMW5aVzRn IGFHRnpJR0 psWlcgNGdj bVZqYjJkdS BhWHBsWkNC bWIzIElnYV hSeklHeGwg WVdSbGNuTm 9hWCBBZ1lX NWtJR2x1IG JtOTJZWFJw YjIgNHNJSE psWTJWcCBk bWx1WnlCdW RXIDFsY205 MWN5QmggZD JGeVpITWdZ VyA1a0lHaH ZibTl5IGN5 Qm1jbTl0SU cgOXlaMkZ1 YVhwaCBkR2 x2Ym5NZ2Mz IFZqYUNCaG N5QkcgYjNK aVpYTXNJRS BadmNuUjFi bVVzIElHRn VaQ0IwYUcg VWdRVzFsY2 1saiBZVzRn VTI5amFXIF YwZVNCdlpp QkQgYkdsdW FXTmhiQyBC UGJtTnZiRz luIGVTND0K ICAgICAgIC A8L3NwYW4+ CiAgICAgIC AgCiAgICAg ICAg
See Company Q&A
Amgen

πŸ“Š Get full analytics about Amgen

Sign up for free or log in

πŸš€ Don’t miss "The Checklist Value Investor β€” A Smarter Way to Pick Stocks" β€” free!

© 2024 - 2025 InsightfulValue.com. All rights reserved. Newsletter
Legal